The GOG Foundation. Inc.

The GOG Foundation, Inc. is a non-profit organization that provides administrative, financial, and programmatic support for cancer research groups through federal grants. GOG supports the research mission and operations of groups like NRG Oncology by carrying out activities related to grant management, regulatory compliance, communications, and more at research centers across the country.

Through subawards from federal grants to prime recipients like NRG Oncology Foundation and the University of Pittsburgh and Chicago, GOG has helped provide programming services, IT support, website development, data management, statistical analysis, tissue sample collection, and other operational activities to enable and support large-scale oncology clinical trials research. Specific cancer research studies GOG has supported through federal grant subawards include the NRGGY022 pharmacokinetics trial and the NCI ETCTN Phase I Emphasis grant awarded to the University of Pittsburgh. GOG's subaward funding has come from National Cancer Institute and other NIH grants managed by prime recipients leading multi-site cancer research programs.